Physicians’ Opinions Survey on FDA’s Bydureon Approval

2012-03-06
Published : Mar-2012

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2016

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides informati......
$1500

Global Micro Guide Catheters Market 2017-2021

About Micro Guide Catheters A micro guide catheter (also known as microcatheter) is a very small single lumen device used on a guidewire to track or help a physician to target a lesion or to cross the lesion. The microcatheter gives mechanical support to the guidewire and enhances its ability to transmit force (pushability and trackability) to the occlusion. The analysts forecast global micro guide catheters market to grow at a CAGR of 8.75% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global micro guide catheters market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of micro guide catheters. The market is divided into the following segments ba......
$3500

Global Surgical Waste Management Market 2017-2021

About Surgical Waste Management Waste that is generated during surgical processes is known as surgical waste. Surgical waste is both hazardous and non-hazardous. Out of the waste generated from surgeries, 85% is non-hazardous and 15% is hazardous. Surgical waste is a huge threat to the environment. Hence, it necessitates proper disposal. Annually, around 250 million surgeries are carried out across the globe, which results in the bulk generation of surgical waste. On average, annually, more than two million tons of surgical waste is being generated. Each day, 5,500 tons of surgical waste is being generated, out of which, approximately 825 tons is hazardous surgical waste. Injections and syringes constitute the bulk of medical waste. Globally, each year, more than 12 billion injections are......
$3500

Global Upper Extremities Market 2017-2021

About Upper Extremities The term "extremity" is generally used to refer to a person's limbs and related parts. Upper extremities include the shoulders, hands, elbows, forearms, wrists, and fingers. Lower extremities consist of the feet, toes, ankles, knees, shins, and thighs. The extremity products are used to treat, repair, replace, or heal extremity injuries such as fractures or damage. These products include external recovery braces, surgical implants, joint replacements, biologics, and external support implants. The analysts forecast global upper extremities market to grow at a CAGR of 6.84% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global upper extremities market for 2017-2021. To calculate the......
$3500

Global Dental Consumables Market 2017-2021

About Dental Consumables Dental consumables are a set of different dental products that are used in individuals to treat dental impairments, for tooth restoration, and in the treatment of associated gingival tissues. Dental consumables are a set of different dental products that are used in dental procedures. Dental implants are the commonly used dental consumables in the tooth restoration procedures. The major causes of tooth loss are tooth decay, gingivitis, injuries, congenital defects, root canal failure, and excessive wear and tear. Osseointegration is a popular procedure adopted by dentists to lock the implant directly into the jawbone. Dental implants are available in different colors and can be customized. The analysts forecast global dental consumables market to grow at a CAGR......
$3500

Global Bone Cement Mixer Devices Market 2017-2021

About Bone Cement Mixer Devices liquid (accelerator) to fill the space between prosthesis and bone deformities. Many new advanced bone cement mixing devices are being developed to decrease the amount of bubble formation and reduce fumes during mixing. The global bone cement mixer devices market is likely to grow at a CAGR of 4.11% during the forecast period. The use of bone cement in interventional procedures such as vertebroplasty and kyphoplasty is on the rise, which will aid the market growth. Increasing prevalence of orthopedic disorders and growing number of orthopedic surgeries also contribute to the market growth. The Americas comprised the majority share of the market in 2016, but APAC is expected to grow at a higher rate during the forecast period. The analysts forecast global......
$3500

Global Chiropractic Care Market 2017-2021

About Chiropractic Care Chiropractic is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. It is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. The analysts forecast global chiropractic care market to grow at a CAGR of 3.67% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global chiropractic care market for 2017-2021. To calculate the market size, the report considers the revenue generated from ......
$3500

Global Angiography Catheters Market 2017-2021

About Angiography Catheters To treat cardiac diseases such as CAD, physicians perform angiography, which requires catheterization to provide diagnostic and therapeutic treatments. Most of the cardiac catheterization procedures involve access through the femoral and radial arteries. Cardiac catheterization through the femoral artery is a traditional procedure, and is preferred by many physicians. However, many physicians are shifting toward radial artery-based catheterization access as traditional procedures have many complications that can even cause death in certain cases. An angioplasty procedure can be performed by widening the narrow blood vessel (plaqued blood vessel). To view and perform the angioplasty procedure, various types of angiography catheters are used. The analysts fore......
$3500

Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017

Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017" provides an overview of Age Related Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDa......
$2500

Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Pancreatic Cancer Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500